BMI is associated with lower blood PSA levels and a larger prostate size, such that potential stage-specific associations between obesity and prostate cancer may be an artifact of factors that influence the ability to detect prostate cancer [32]. The gene discussed is KLK3; the disease is obesity due to melanocortin 4 receptor deficiency.